- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Chromogranin A antibody recognizes Chromogranin A, a secretory granule glycoprotein encoded by the CHGA gene and a well-established marker of neuroendocrine differentiation. Chromogranin A Antibody Recombinant Mouse MAb (clone rCHGA/413) is engineered through recombinant expression to provide consistent performance and lot-to-lot reproducibility in research applications. Chromogranin A localizes predominantly to the cytoplasm within dense-core secretory vesicles of endocrine and neuroendocrine cells, where it contributes to hormone storage, granule maturation, and regulated secretion.
Chromogranin A antibody, also referred to as CHGA antibody, CgA antibody, and CGA antibody in the literature, targets a member of the granin family of acidic secretory proteins. Following synthesis, Chromogranin A undergoes proteolytic processing to generate biologically active peptides such as vasostatin, pancreastatin, and catestatin. These peptides are involved in modulation of cardiovascular tone, glucose metabolism, and neuroendocrine signaling pathways. Within the trans-Golgi network, Chromogranin A promotes aggregation of peptide hormones and supports formation of stable dense-core secretory granules.
CHGA expression is characteristic of adrenal medulla chromaffin cells, pancreatic islet cells, gastrointestinal enteroendocrine cells, parathyroid gland, and dispersed neuroendocrine cell populations throughout multiple organ systems. The expected staining pattern is cytoplasmic granular positivity reflecting localization to secretory vesicles. Because of this lineage-restricted distribution, Chromogranin A is widely used in research to identify neuroendocrine differentiation and to study secretory pathway biology.
In tumor biology investigations, Chromogranin A expression is frequently evaluated in neuroendocrine neoplasms including carcinoid tumors, pancreatic neuroendocrine tumors, small cell carcinoma, medullary thyroid carcinoma, and pheochromocytoma. Strong cytoplasmic staining supports neuroendocrine lineage, whereas most non-neuroendocrine carcinomas demonstrate limited or absent expression. Chromogranin A Antibody Recombinant Mouse MAb (clone rCHGA/413) enables reliable detection of Chromogranin A expression patterns in normal and neoplastic tissues for research use at NSJ Bioreagents.
Optimal dilution of the Chromogranin A antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Recombinant human protein was used as the immunogen for the Chromogranin A antibody.
Store the Chromogranin A antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.